Stereotactic radiosurgery and radiotherapy. Radiobiology and treatment planning by Novotný, J. et al.
J.Novotny et al.: Stereotactic radiosurgery and radiotherapy....
STEREOTACTIC RADIOSURGERY AND RADIOTHERAPY.
RADIOBIOLOGY AND TREATMENT PLANNING.
J.NOVOTNY, V.VLADYKA, R.L1SCAK, D. URGOSiK, G.SIMONOvA, J.NOVOTNY, JR.
Hospital Na Homolce, Department of Stereotactic and Radiation Neurosurgery
Roentgenova 2, 15119 Prague 5, Czech Republic
INTRODUCTION
Stereotactic radiosurgery (SR) is the
treatment of small lesions in the brain using
external beams of radiation. The treatment is
performed in one single fraction with the use of
high dose. The beams are guided to the desired
point within the brain using very accurate, 3-
dimensional imaging procedures (Leksell, 1951).
Stereotactic radiotherapy (SRT) is the
treatment of small or medium lesions in the
brain with fractionated regimes employing
stereotactic method. This procedure differs from
conventional radiotherapy in that the volume of
tissue is usually smaller, the number of fractions
delivered is much smaller, and the dose per
fraction is much larger. The strategy of
radiosurgery or stereotactic radiotherapy is to
use the localisation of a high radiation dose to
the volume of the target lesion to effect the
desired biological sequalae, while sparing
adjacent normal tissues.
Although stereotactic radiosurgery has
traditionally been kept distinct from radiotherapy,
the two fields are rapidly converging. In SR and
SRT, improved dose localisation is achieved by
using stereotactic apparatus to pinpoint the
target volume, and by using special irradiation
schemes and technology to deliver it precisely.
Dose distributions with steep fall-off have been
achieved primarily by a large number of ports or
arcs (photon SR or SRT) or by improved depth
dose characteristics (charged particle SR and
SRT). Radiotherapy, too, is riding a wave of
technological achievements that is carrying it to
ever better dose distributions. Multileaf
collimators, sophisticated 3-dimensional treat-
ment planning programs for conformal therapy,
computerised delivery systems, on-line portal
imaging systems and megavoltage X-rays are
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all components of this effort. Improved diagnosis
and better target localisation with CT and MRI
are helping to heighten confidence in the volume
needed to be treated. In the future, then, the
advantages and techniques of
radiosurgery and stereotactic radiotherapy will
become of more interest and use to the
radiotherapist, and they will take their place
alongside the other, more established, methods.
STEREOTACTIC TREATMENT PROCEDURE
The flowing chart diagram showing the
stereotactic procedure for SR or SRT is shown
in Fig. 1. The individual procedures are closely
connected and must be performed conse-
quently, usuallY,in one day.
Indication criteria for SR or SRT are beyond the
scope of this paper. Shortly speaking, the aim of
SR and SRT is a choice of the most effective
and most delicate treatment for the patient.
Although neurosurgery disposes with many
refined techniques, especially of microsurgery,
and remains the standard treatment when both
patient and the physician are willing to undertake
the risks of such procedure, sterotactic
radiosurgery or radiotherapy offers an excellent
alternative to this.
There are some very important advantages for
SR and SRT such as shortening of hospita-
lisation, sparing of social position, avoidance of
operational risks and unexpected lowering of cost
of the treatment, as well. Between disadvantages
of SR and SRT belong delayed time of cure
(0.5-3 years), lesion control instead of removal,
insufficiency to resolve acute states, limitation by
radiosensitivity of critical structures.
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Fig. 1. : Flowing chart diagram for the stereotactic radiosurgery or stereotactic radiotherapy procedure.
Criteria for the choice of patient for SR and SRT depend mainly on the histology, volume and location
of lesion, health condition of patient, etc. In principle four main groups can be identified in SR and SRT
treatment: (a) functional; (b) benign tumours; (c) malignant tumours; and (d) vascular malformation.
Number of treated malignant tumours' is increasing with the development of linac stereotactic
technology very rapidly and it is expected that in near future it will be competitive with other three
groups.
RADIOBIOLOGY OF RADIOSURGERY AND
STEREOTACTIC RADIOTHERAPY
At radiosurgery or stereotactic radiotherapy
narrow radiation beams are directed
stereotactically to produce radiobiological effects
within a carefUlly defined small intracranial
volume. The desired effects within this target
volume following a single treatment include
blood vessel thrombosis and/or reproductive cell
death. The common experience indicate that
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one can usually avoid delivering clinically
significant dose beyond the target volume, in
part because of the steep dose gradient at the
target periphery and in part because most
practitioners require the minimum dose to target
isodose contour often as low as 50% of
maximum-to closely conform to the 3-D target
configuration. Interior to the target contour,
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therefore, radiosurgery doses are often high and
inhomogenous and results in larger variations in
radiobiologic effect within and adjacent to the
target volume than would be expected following
a course of fractionated treatment. This is due to
the degree of curvature of cell survival curves
obtained with X-rays or gamma rays, which may
be very large for normal human glial cells and for
many radiosurgery targets. Therefore, interior to
the target periphery, small increments of dose
often have a disproportionate radiobiological
effect, which is accentuated by the steep
gradient, and may increase likelihood of cure of
complication. Beyond the target tissue, on the
other hand the isodose curves would suggest,
possibly decreasing normal tissue effects or
decreasing the response of infiltrative cells
beyond the apparent target periphery.
The first radiobiological principle of
importance here is that malignant tumors, even
of those of limited size, usually contain a
proportion of hypoxic cells that, because of their
deficiency in oxygen, are resistant to killing by X
rays or gamma rays (Larson et aiL, 1993; Hall
and Brenner, 1993). The cellular survival curve
for malignant cells is characterised by having
two components; the slopes of the two
components differ by factor of 2.5 to 3. Up to
doses of several Gy, the response is dominated
by killing of aerobic cells, while for higher dose,
the killing of hypoxic cells dominates. It is
immediately apparent that irradiating these
tumor cells with single large dose of several tens
of Gy will not kill all the cells, because the dose
of this size will not be adequate. However, it is
well known fact, that tumors exhibit a
characteristic known as reoxygenation whereby,
between fractionated doses of X rays and
gamma rays, tumors tend to re-establish their
original pattern and proportion of oxygenated
and hypoxic cells. In a fractionated regime,
therefore, each dose of X-rays or gamma rays
predominately kills aerobic cells, and the interval
between treatments allows hypoxic cells to re-
establish their oxygenated state.
The second radiobiological principle is
based upon a wealth of experimental evidence
that indicate that there is a difference in shape
between the dose response relationship
characteristic of early responding tissues and
tumors, and late responding tissues. In
mathematical terms, if the dose-response
relationship is expressed with a linear-quadratic
relation where cellular survival, S, is then the
ratio of alb tends to be small for late responding
tissues « 3 Gy) and larger (> 8 Gy) for early
responding tissues. The practical consequence
of the difference in shape between the dose-
response curves for early and late responding
tissues is a marked difference in the response to
fractionation of these two types of tissues. Late-
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responding tissues are more sensitive to changes
in fractionation than early-responding tissues.
The linear-quadratic formalism is now a
generally accepted and proven tool in the field of
radiation oncology for comparing the early and
late effects of different fractionation schemes.
The magnitude of different effects obtained from
radiosurgery and fractionated radiotherapy can
be seen from Fig. 2 where is a plot of
radiosurgery dose versus total fractionated dose
at 2 Gy per fraction necessary to produce the
same radiobiological effects, both for late
responding tissue (a/b=2.5, upper curve) and for
early responding tissue (alb =10, lower curve)
This figure is based on biologically effective dose
(BED) formalism recently reviewed by Fowler
(1992) in which:
BED = RSD * (alb + RSD)I (alb)
= TFD *( alb + d)1 (alb) - n* 0.693 la,
where RSD - radiosurgery dose, TFD - total
fractionated dose, d - daily dose,
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Fig. 2: Radiosurgery dose (RSD) versus total fractionated
dose (TFD) at 2 Gy per fraction necessary to produce the
same radiobiological effects.
Calculation has been simplified by assuming that
the last term in the above equation is negligible.
Without this approximation, the total fractionated
dose corresponding to a given RSD would be
somewhat large. It is obvious that using this
formalism it is possible to construct curves for
different values of alb andlor to calculate different
fractionated or protracted stereotactic regimes.
It is useful to categorise potential
radiosurgery target according to whether the
target tissue is early or late responding and
according to whether it is embedded within or
only surrounded by normal tissue. It is assumed
that normal relevant tissue consists mostly of
low alb, late responding tissue (glial cells, for
example) and it is also distinguished target
volumes that contain only abnormal tissue from
those containing both abnormal and normal
tissues. All radiosurgical target can be attributed
to one of the categories given in the Table 1.
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Table 1: Definition of different categories of radiosurgical targets.
Cateqorv Description Example (a/bhu/( a/b)NT Fractionation
I. late-responding target embedded low/ low NO
within late-respondinq normal tissue AVM
II. late-responding target surrounded by low/low POSSIBLE
late-responding tissue meninqeoma
III. early-responding target embedded within low grade high/low YES
late-respondinq tissue astrocytoma
IV. early-responding target surrounded high/low YES
bV late-responding tissue metastases
Radiosurgery volumes are usually less
than a few centimetres in maximum dimension.
This target size limitation is based on clinical
experience showing that radiosurgery
complications are much strongly associated with
target size than with dose, and thus related to
the volume of normal tissue-receiving significant
radiation dose. For radiosurgery targets
surrounded by normal tissue and for those
embedded in normal tissue the dose is
delivered to a thin rim of normal tissue just
beyond the target periphery. The volume of the
rim is proportional to the square of target radius.
For radiosurgery of targets embedded in normal
tissue, significant dose is delivered additionally
to any normal tiss,ue within the target volume.
This volume is proportional to the cube of the
target radius. For either type of target, therefore,
unavoidable geometrical factors results in a
rapid increase in the volume of normal tissue
receiving significant dose as target size
increases.
Regarding AVM, it is clear that the
radiobiological principles do not imply any
particular radiobiological advantage if one
fraction scheme over another. Generally it is
accepted that radiosurgery for small AVM is
better than fractionated irradiation. It is not
recommended to treat, either by the
radiosurgery or by the fractionated irradiation,
large AVM because doses likely to be curative
are to cause clinically unacceptable levels of
normal tissue damage.
Regarding malignancy, it is clear that
fractionated schemes are potentially superior to
radiosurgery for small malignancies, at least in
principle, especially if one ignores the possible
effects of radiosurgery on vessels within the
target volume. On the basis of basic
radiobiological principles applicable to tumor
radiotherapy, it would seem important that, when
stereotactic fractionated 'radiotherapy for
treatment of malignancies situated in the brain is
used, moderate number of fractions (around five
to six) should be used. By contrast, single-
fractionated treatment of a malignancy would be
expected to give suboptimal therapeutic ratio
between tumor control and late complications.
Fractionated regimes using five or six fractions
can be calculated using above equations for
early and late responding tissues to produce the
same radiobiological effects. Examples are
given in tab. 2 (ignoring proliferation during
treatment).
It is worth mentioning that stereotactic
fractionated techniques have several
advantages over conventional fractionated
techniques, chief of which is that the desired
target volume-and only the target volume-
receive full dose irradiation in a highly
reproducible manner. This can only improve the
therapeutic ratio.
Table 2: Radiosurgery dose and corresponding total radiotherapy dose to produce a similar radiobiological effect, for late (alb
=2.5) and early responding tissue (alb =10) .
Total fractionated dose rGv]
2.5 Gv/fraction 6 Gy/ fraction
Radiosurgery dose a/b=2.5 alb =10 alb=2.5 alb =10
10 Gv 27.8 16.7 14.7 12.5
20 Gy 100 50 53 37.5
30 Gv 216.7 100 114.7 75
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TREATMENT PLANNING
Treatment planning procedure consists
in principle from three components: target
volume delineation in 3D using stereotactic
images and evaluation of co-ordinates, dose
distribution calculation in 3D and treatment time
or monitor unit calculation for selected dose. The
aim of dose distribution calculation is to tailor
isodose curves around the target volume, that is
the spatial dose distribution must be shaped so
that the maximum dose volume always is
located within target volume. Generally it is
ambition to shape the dose distribution so that
the border of the target is circumscribed by a
dose surface of 80 to 50 % of the dose
maximum. This reflects the ambition to combine
a homogenous distribution within the target and
rapid fall off at its periphery.
Criteria for selection of absorbed dose
levels for individual cases are based on three
major factors: a) histology of the surgical target;
b) target volume, and c) by proximity of critical
structures close to the target. The dose is
usually prescribed at the periphery of the target
but sometimes, and particularly for functional
disorder treatment the maximum dose is used.
Sometimes the dose to maximum is limited by
the tolerance of dose to critical structure, for
example to brain stem.
The treatment planning system depends
on the treatment techniques used in the
department. There are available commercial
treatment planning system, like GAMAPLAN or
KULA for Gamma Knife, X-KNIFE from
RADIONIX for Varian stereotactic system,
STEREPLAN PLUS for Leibinger system,etc. It
is quite obvious that special stereotactic
techniques require special input data for therapy
machine and patient's input data. It is therefore
impossible to explain here even different
systems used, and therefore only basic ideas of
treatment planning procedure will be outlined.
The safe administration of the large single or
mUltiple fraction doses of irradiation used in SR
or SRT is made possible by a combination of the
small size of the treatment fields used and the
close matching of the treatment volume with the
target volume facilitated by stereotactic
localisation techniques. Circular collimators are
used with Gamma Knife and with most linear
accelerator stereotactic techniques. The use of
circular collimators results in treatment volumes
which are fairly spherical in shape. Depending
on the techniques used and the position of target
volume within skull, the treatment volume may
be elongated diameter in one particular direction
or can be quite irregular. When the target
volume to be treated deviates significantly from
the shape of the roughly spherical treatment
volume for SR or SRT with a single isocenter it
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is helpful to change the shape of the treatment
volume to limit the amount of high dose
irradiation to surrounding tissues. The shape of
treatment volumes can be basically modified by
(Phillips, 1993):
a) combination of different collimators in one
isocenter; b) selective blocking; c) using multiple
isocentric irradiation; d) using different weights
for different shots; e) change of "gamma angle",
Le. different position of patient's head; f) change
of dose rate for different entrance angles.
The use of selective blocking makes a
treatment of irregular target volumes more
conformal and provides less dose to critical
structures. Selective beam blocking appears to
be useful technique for shaping radiosurgical
dose distributions for all stereotactic techniques,
especially when treating a targetvolume situated
directly underneath and important and/or
radiosensitive structure as optic chiasm. The
combination of mUltiple isocenter treatment
techniques with selective beam blocking is a
particularly useful for irregular tumors such as
acoustic neurinomas.
Optimisation of alternative results of treatment
planning within one medical centre and the
increasing interest of various centres in
stereotactic SR or SRT make it necessary that a
basis of evaluation and comparison be found.
Two-dimensional isodose contours overlaid on
the main anatomical structures and dose volume
histograms may possibly provide such a basis.
Evaluation of such treatment planning results is
frequently done merely by qualitative analysis by
an experienced neurosurgeon. A more
quantitative evaluation is facilitated by dose-
volume histograms. The problem of evaluation
as a whole, however, is not yet sufficiently
solved and remains to be done in the future.
Each treatment plan has to be optimised
from three basic aspects: firstly from the point of
absorbed dose conformation including absorbed
dose level used for treatment; secondly, for
critical structures near the target volume; thirdly,
for radiobiological aspects. It is necessary to
optimise the expected outcome of the treatment
and possible risk having consequences in
increased morbidity. Optimisations of treatment
plan, mostly based on previous experience, is a
fundamental part of the treatment, but patient's




stereotactic radiotherapy is an attractive therapy
because a)it is efficacious for treating lesions in
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inaccessible regions of the brain; b) morbidity
and mortality are low ( there is almost no risk of
infection or haemorrhage);c) treatment is quick
and precise.
In future, it is likely that the previously
sharp distinction between radiosurgery and
radiotherapy will become increasingly blurred.
Radiotherapists are expeditiously applying the
well-confined dose distributions available with
stereotactic methods. While appropriating the
dose localisation characteristic of radiosurgery,
they must acknowledge the biological
characteristics of each specific lesion being
treated. New fractionation schedules are being
explored, and new methods for tailoring the dose
distribution to the target volume are being
developed. From the neurosurgical side,
radiosurgery has become one more tool in the
neurosurgeon's stereotactic toolkit whose role in
the treatment of various diseases is being
explored. Another trend in the use of SR and
SRT as but one step in a multi-modality
treatment that can include surgery,
chemotherapy, and embolization..
Development in the physics of
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stereotactic SR and SRT will, no doubt, parallel
those occurring in radiation therapy. Namely,
better improvements in treatment will rely on
better treatment planning algorithms; precise,
reliable and for patient more confortable
positioning techniques will be developed and
used.
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